Methylfolate (L-5-MTHF)
Also called: L-methylfolate, 5-methyltetrahydrofolate, 5-MTHF, L-5-MTHF, 5-methyl-THF
5-Methyltetrahydrofolate (5-methyl-THF, L-methylfolate), the main form of folate in plasma. It is a reduced form of folate that is also available in dietary supplements. General folate information is in the folate entry.
- Category
- Vitamin
- Forms
- L-5-methyltetrahydrofolate as calcium, glucosamine or dicholine salt; 6(S) and 6(R,S) forms appear on FDA's NDI list
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. A 2022 systematic review included nine articles (6,707 patients) on adjunctive L-methylfolate in depressive disorders; its meta-analyses pooled three studies (483 patients) and four studies (507 patients). [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BBrain, mood and sleep2 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Depression, added to antidepressant treatment | B | A 2022 meta-analysis found a small benefit of adjunctive L-methylfolate over antidepressant alone (response relative risk 1.25, 3 studies, 483 patients; symptom SMD -0.38, 4 studies, 507 patients). [2] |
| Depression: dose comparison with SSRIs | C | ODS describes trials in which 15,000 mcg/day 5-methyl-THF plus an SSRI for 60 days improved depression versus SSRI plus placebo, whereas 7,500 mcg/day for 30 days then 15,000 mcg/day did not. [1] |
Main constituents: 5-Methyltetrahydrofolate (5-methyl-THF), a reduced form of folate [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Depression trials described by ODS used 7,500-15,000 mcg/day 5-methyl-THF for 30-60 days with an SSRI; ODS notes many folate doses used in depression studies exceed the UL and should be taken only under medical supervision. [1]
Upper limits
- UL for folate from supplements or fortified foods, adults 19 and older (including pregnancy and lactation): 1,000 mcg/day. The UL covers synthetic forms such as folic acid and 5-methyl-THF and does not apply to people taking high doses under medical supervision. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingODS: the folate UL of 1,000 mcg/day from supplements or fortified foods also applies in pregnancy and lactation.
1 statement in the profile.
Details and sources - Interactions with medicines3 listed
Methotrexate; Antiepileptic drugs (phenytoin, carbamazepine, valproate); Sulfasalazine
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications9 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- ODS: high intakes of folate supplements might mask vitamin B12 deficiency until its neurological consequences become irreversible; concern has also shifted to the potential for large amounts of folate to precipitate or exacerbate the anemia and cognitive symptoms of B12 deficiency. [1]
Interactions
| With | What happens |
|---|---|
| Methotrexate | ODS (folate): methotrexate is a folate antagonist; people taking it for cancer should consult their oncologist before taking folate supplements, which could interfere with its anticancer effects. [1] |
| Antiepileptic drugs (phenytoin, carbamazepine, valproate) | ODS (folate): these medications can reduce serum folate levels, and folate supplements might reduce serum levels of these drugs. [1] |
| Sulfasalazine | ODS (folate): sulfasalazine inhibits intestinal absorption of folate and can cause folate deficiency. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- ODS: the bioavailability of 5-methyl-THF in supplements is the same as or greater than that of folic acid, but conversion factors to dietary folate equivalents (DFE) for 5-methyl-THF have not been formally established. [1]
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- 5-Methyltetrahydrofolate (L-5-MTHF, L-methylfolate) Reduced folate (vitamin B9) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 9 entries naming 5-methyltetrahydrofolate or one of its salts (calcium, glucosamine or dicholine) (earliest NDI 26 submitted 1998-02-26; most recent NDI 1434 submitted 2025-08-15). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Methotrexate: ODS (folate): methotrexate is a folate antagonist; people taking it for cancer should consult their oncologist before taking folate supplements, which could interfere with its anticancer effects. [P5]
- Antiepileptic drugs (phenytoin, carbamazepine, valproate): ODS (folate): these medications can reduce serum folate levels, and folate supplements might reduce serum levels of these drugs. [P5]
- Sulfasalazine: ODS (folate): sulfasalazine inhibits intestinal absorption of folate and can cause folate deficiency. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- ODS: bioavailability of 5-methyl-THF in supplements is the same as or greater than that of folic acid; DFE conversion factors for supplemental 5-methyl-THF have not been formally established. [P5]
- ODS: people homozygous for the 677C>T MTHFR polymorphism have an impaired ability to convert folate to 5-MTHF and might benefit from supplementation with 5-methyl-THF. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- ODS: the folate UL of 1,000 mcg/day from supplements or fortified foods also applies in pregnancy and lactation. [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- NIH Office of Dietary Supplements. Folate: Fact Sheet for Health Professionals (Updated: October 4, 2018), 2018-10-04. ods.od.nih.gov
Sources
- NIH Office of Dietary Supplements. Folate: Fact Sheet for Health Professionals (Updated: October 4, 2018), 2018-10-04. ods.od.nih.gov
- Maruf AA, et al. Systematic review and meta-analysis of L-methylfolate augmentation in depressive disorders. Pharmacopsychiatry 2022;55(3):139-147 (PMID 34794190), 2022-05. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · Thiamin (vitamin B1) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.